Gemtuzumab ozogamicin (CAT#: TP-107CL)
Recombinant humanized IgG4, kappa antibody conjugated with a cytotoxic antitumor antibiotic, calicheamicin, isolated from fermentation of a bacterium, Micromonospora echinospora ssp. calichensis. The antibody portion of Mylotarg binds specifically to the CD33 antigen, The anti-CD33 hP67.6 antibody is produced by mammalian cell suspension culture using a myeloma NS0 cell line. Gemtuzumab ozogamicin (trade name Mylotarg) was withdrawn in 2010 when a clinical trial showed the drug increased patient death and exhibited no advantages over traditional cancer therapies.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
Specifications
- Type
- Biotech
- Trade name
- Mylotarg
- UNII
- 8GZG754X6M
Target
- Function
- Humanized anti-CD33 IgG4k mAb conjugated to calicheamicin, a small-molecule chemotherapeutic agent
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
Customer Review
Q&As
Highly effective
Our lab used Gemtuzumab Ozogamicin for in vitro cytotoxicity assays on AML cell lines. The product was highly effective, and we observed consistent results across various experimental setups. Highly recommend for research!
Clear instructions
Storing Gemtuzumab Ozogamicin was straightforward with clear instructions. However, remember not to agitate the solution too much during handling. It's sensitive but immensely powerful for targeted research.
Great product for research
A great product for those researching CD33+ malignancies. Be sure to handle with care and follow all storage recommendations. The cytotoxic effects are profound and very specific to the target cells.
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TP-107CL, RRID: AB_3112057)
Copy citation
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: Neut, ELISA, IF, IP, FuncS, FC, IHC
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
-3-1.png)
Application: WB, ELISA, Neut, FuncS
Application: ELISA, FC, Neut, Inhib
Application: ELISA, FC, WB, Inhib, IHC
Application: ELISA, IHC, WB
Application: ELISA, WB, IF, FC, IP
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
